Breaking AI & Tech News Analyzed

The Uncanny podcast has evolved from a simple Radio 4 paranormal investigations podcast to a global franchise, including live stage shows, a TV series, and a US spinoff.Host Danny Robins, known as the 'high priest of the paranormal,' has captivated audiences with spine-tingling stories, dissecting each tale with parapsychologists Evelyn Hollow and Ciarán O’Keeffe.The podcast's success can be attributed to its unique format, featuring 8 million+ downloads within two years, and its expansion into various media, including a new YouTube channel focused on classic cold cases.The Uncanny community has grown to millions, with fans bonding over shared experiences and discussing cases on social media, showcasing the power of prestige paranormal storytelling.Experts attribute the podcast's appeal to its blend of drama and true crime elements, making it a detective story that keeps listeners engaged and curious.As Uncanny continues to grow, with plans for international tours, new TV series, and conventions, its impact on popular culture and the paranormal genre is undeniable, reflecting our society's increasing fascination with the supernatural.

The Guardian’s weekly podcast roundup highlights a varied selection of new audio series, offering listeners everything from light‑hearted celebrity banter to hard‑hitting investigative journalism.Funny You Ask – In a delightfully candid moment, Mindy Kaling exclaims, “Oh, this is a quizshow?!” upon hearing Ike Barinholtz’s latest podcast, which blends trivia with rambling conversation about topics as eclectic as Chevy Chase and New Jersey Italian cuisine. The show positions itself as a breezy, low‑stakes alternative to the crowded celebrity‑interview market.Assume Nothing: What Happened to Mary Glasgow? – Host Nathan Edgar revisits the 1991 tragedy at Stradreagh mental hospital, where nursing assistant Mary Glasgow died after a patient altercation. Through interviews with Glasgow’s daughter Emma, the series treats the case as both a detective narrative and a memorial, probing whether the incident was an isolated mishap or a symptom of systemic failures.Single Ladies in Your Area – Comedians Amy Gledhill and Harriet Kemsley continue their third series, a witty exploration of 30‑something singledom. Recent guests have included Jameela Jamil and Catherine Bohart, who discuss topics ranging from “mean flirting” to the quirks of a “lesbian louche life.”The Overturn – Partnering with the Future Justice Project charity, Marnie Duke examines potential wrongful convictions, notably the case of former sub‑postmaster Robin Garbutt, imprisoned for his wife’s murder. The series asks whether the broader Post Office scandal could cast doubt on the prosecution’s narrative.Amityvilleville – Host Alex Goldman (of Hyperfixed and Reply All) teams up with Vice writer Caroline Thompson to watch all 91 films inspired by the Amityville haunting, beginning with the 1979 classic The Amityville Horror. Their commentary blends humor with genuine enthusiasm for the genre’s most bizarre entries.

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

The conflict between the United States, Israel and Iran is now spilling onto academic grounds. The Islamic Revolutionary Guard Corps (IRGC) publicly warned U.S. universities in nearby nations following weekend attacks on two Iranian campuses.According to Tehran‑based sources, at least 21 Iranian universities have sustained damage since the war erupted. The targeting of educational institutions marks a troubling escalation, raising questions about the strategic value of universities in modern warfare.In a recent podcast episode, Setareh Sadeqi, an assistant professor at the University of Tehran, discusses the motivations behind these strikes and the broader implications for Iran’s higher‑education sector. The program, produced by Al Jazeera’s AJ E Podcasts team, also explores how the “war on Iran” is extending beyond traditional battlefields into classrooms and research labs.Key takeaways include the IRGC’s threat to retaliate against U.S. institutions, the potential impact on international academic collaborations, and the symbolic message that disrupting knowledge hubs can weaken a nation’s resilience.Listeners can follow the discussion on X, Instagram, Facebook, or YouTube via @AJEPodcasts.

Palantir’s senior UK representative has warned ministers against yielding to ideologically motivated campaigners as they explore the possibility of terminating a £330 million NHS contract for the company’s Federated Data Platform (FDP).The FDP, an AI‑enabled system intended to unify patient information across the health service, is part of a broader portfolio that includes contracts with the Ministry of Defence, several police forces and the UK’s financial regulator.Louis Mosley, executive vice‑chair of Palantir UK, told The Times that abandoning the deal would jeopardise patient care and hinder progress on the NHS’s most pressing challenges. He highlighted that the platform is projected to generate £150 million in benefits by the end of the decade, delivering a £5 return for every pound spent.According to the Financial Times, senior officials have begun informal discussions about activating a break clause that would allow the FDP’s operation to be transferred to an alternative provider once the system becomes fully operational next year.Palantir, a US‑based data‑analytics firm with ties to the Israeli and US militaries and former U.S. Immigration and Customs Enforcement contracts, has faced sustained opposition from the British Medical Association, which has long criticised the use of its technology in patient‑care settings.Health officials acknowledge the reputational risk, noting that the controversy now extends beyond traditional Labour‑left and Green Party critics. A Department of Health and Social Care spokesperson emphasised that the FDP is designed to improve care coordination, accelerate cancer diagnoses and increase treatment capacity, while maintaining strict data‑security safeguards.Health Secretary Wes Streeting, speaking on the Guardian Politics Weekly podcast, recognised public unease about Palantir’s political affiliations, referencing founder Peter Thiel’s right‑wing connections. He reassured listeners that Palantir does not have direct access to patient data, stating, "The platform is operated by us; Palantir never sees the data."Adoption of Palantir’s technology within the NHS has risen from 118 to 151 organisations since June, though it remains short of the government’s target of 240 organisations by year‑end. Labour backbencher Clive Lewis noted that the issue is becoming a visible concern for voters, reflecting broader anxieties about AI and foreign‑owned infrastructure in critical public services.

As gas prices surge past $4 a gallon, Donald Trump's approval rating has plummeted to 33%, the lowest during his second term, according to a University of Massachusetts Amherst poll. The war on Iran, which has led to rising fuel costs, is becoming a liability for the Republican party.JD Vance, the vice-president and potential 2028 Republican presidential candidate, is attempting to distance himself from the Iran conflict. Sources close to Vance are speaking out, claiming he has always been against the war. Axios reported that Vance had expressed skepticism about Israel's prime minister, Benjamin Netanyahu, over the war.Vance's wife, Usha, is also gearing up for a public role, launching a podcast called 'Storytime With the Second Lady' aimed at children, a move seen as an attempt to build a positive public image ahead of the 2028 election.Despite these efforts, Vance's charisma and credibility are being questioned. His appearance on The Benny Show podcast, where he discussed UFOs and aliens as 'demons,' has raised concerns about his judgment and appeal to a broader audience.

The Idiot – A fresh five‑part series from the New York Times and Serial Productions, narrated by columnist M. Gessen, follows the unsettling tale of Allen, a self‑styled “idiot” who allegedly orders a hit on his ex‑wife. The narrative blends the investigative depth of earlier Serial hits like We Were Three and S‑Town, delivering a dark, character‑driven thriller that drops new episodes weekly.Friends Keep Secrets – Pop star Selena Gomez teams up with producer Benny Blanco, rapper‑actor Lil Dicky, and his wife Kristin Batalucco for a podcast that pushes the envelope of celebrity banter. Listeners can expect unfiltered conversations that even feature an unexpected Ed Sheeran interview, complete with the kind of raw, off‑beat humor that borders on “brain‑rot” territory.Screwed by AI – Hosted by Avantika Chilkoti of The Economist, this series travels to the Adult Video Network expo in Las Vegas – dubbed the “Oscars of porn” – to explore how the adult‑entertainment sector often foreshadows broader AI trends. The podcast examines the ripple effects on human relationships and the tech landscape, releasing new installments each week.Jacob Reed and Me – Described as an “investigative comedy,” writer Jacob Reed embarks on a nationwide quest to locate every other person sharing his name. The journey becomes a quirky storytelling experiment, featuring encounters with beach‑scene painters, economists, and even porn stars, all while the show’s advertisements are humorously sourced from fellow Jacob Reeds.Raven – This character‑driven investigation follows Raven Chanticleer, the founder of the African American Wax Museum in Harlem. The series weaves together Chanticleer’s flamboyant life story with the mystery surrounding the disappearance of his wax figures after his 2002 death, delivering a richly detailed narrative that unfolds weekly.All six podcasts are widely accessible across major platforms and release new episodes on a weekly schedule, offering a broad spectrum of content for listeners seeking true‑crime intrigue, celebrity insight, technological commentary, and off‑beat humor.

Bob Dylan, the 84-year-old music legend, has taken to Patreon, a platform typically used by podcasters and visual artists, to share exclusive content with his fans. For $5 a month, subscribers can access 'Lectures from the Grave,' a series of AI-generated lectures, letters, and short stories.The choice of platform and content has raised eyebrows, as many major music stars have opted for Substack for their newsletter-style content. The use of AI to generate the content has also sparked debate among fans, with some questioning the authenticity of the posts.The content so far includes a video of gospel singer Mahalia Jackson, a lecture about Wild Bill Hickok, a folk hero of the Old West, and a fictional letter from Mark Twain to Rudolph Valentino. While the connections between these topics and Dylan's past are tenuous, they are in line with his style of often leaving interpretation open to his fans.Dylan's decision to use Patreon and AI-generated content has been met with both curiosity and confusion. Fans are eager to decode the meaning behind his posts, and the $5 a month subscription fee is seen as a way to support the artist. As one fan noted, 'If a man who sold his publishing to Universal for a reported $300m back in 2020 patently doesn’t need the $5 a month subscription fee – although, one might argue, why shouldn’t he be paid for his work? – his fans are doubtless going to view it as money exceptionally well spent.'

Harry Enfield, known for his portrayal of King Charles in The Windsors, presents a comprehensive review of his career in this Audience With … event. The show is a chronological journey through his 40-plus years in comedy, featuring a vast array of personae, catchphrases, and showbiz anecdotes.Enfield's iconic characters, such as Stavros and Loadsamoney, are revived, along with his DJ alter ego Dave Nice, now a right-wing podcaster. The show also includes fresh sketches and performances of his favorite old sketches, like Mr Cholmondley-Warner and Wayne and Waynetta Slob.The comedian's ability to distill personalities and social types into telling tics, speech patterns, or catchphrases is remarkable. He shares engaging background details and biographical snippets, including stories about his family and celebrity encounters with Whitney Houston, Nelson Mandela, and a drunken session with Paul McCartney and George Harrison.This touring show is a treat, offering a trip down memory lane and showcasing Enfield's enduring comedic talent. He solidifies his claim as the head of our comedy state, with a performance that is both nostalgic and engaging.Harry Enfield is set to tour with his show, with upcoming dates at G Live, Guildford, and the Forum, Bath.